Immunotherapy of virus infection
OwnerDavid Charles Jackson, Lorena Elizabeth Brown +2inventors
InventorsDavid Charles Jackson, Lorena Elizabeth Brown, Lau Yuk Fai, Eric James Gowans
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating or preventing a virus infection in a subject. In particular, it relates to the use of autologous dendritic cells that have been matured and loaded ex vivo with hepatitis C virus (HCV) antigens, to initiate a cellular immune response in HCV-positive patients, after autologous transfusion.
Claims22
A method of therapy for treating a viral infection in a subject, the method comprising:
- (a) generating a concentrated ex vivo population of autologous dendritic cells;
- (b) exposing the autologous dendritic cells to lipopetides comprising T helper and viral CTL epitopes and/or antibody epitopes;
- and;
- (c) introducing the autologous dendritic cells into the subject, thus producing an enhanced immune response to the viral infection.
A method of therapy for treating a viral infection in a subject, the method comprising:
- (a) harvesting cells from a subject;
- (b) generating a concentrated population of dendritic cells from the harvested cells;
- (c) exposing the dendritic cells to lipopeptides comprising T helper and viral CTL epitopes and/or antibody epitopes;
- and
- (d) re-introducing the dendritic cells into the subject.
A population of lipopeptide pulsed dendritic cells (DCs) produced according to a method comprising:
- (a) generating a concentrated ex vivo population of autologous dendritic cells;
- (b) exposing the autologous dendritic cells to lipopeptides comprising T helper and viral CTL epitopes and/or antibody epitopes;
- and
- (c) introducing the autologous dentridic cells into the subject.
A population of lipopeptide pulsed dendritic cells (DCs) produced according to a method comprising:
- (a) harvesting cells from a subject;
- (b) generating a concentrated population of dendritic cells from the harvested cells.
- (c) exposing the dendritic cells to lipopeptides comprising T helper and viral CTL epitopes and/or antibody epitopes;
- and
- (d) re-introducing the dendritic cells into the subject.
A method for inducing cell mediated immunity in a subject, the method comprising treating a subject according to the method of the first aspect of the invention for a time and under conditions sufficient to activate a CTL of the subject.
A method for the prophylactic treatment of an uninfected subject, the method comprising:
- (a) generating a concentrated ex vivo population of autologous dendritic cells;
- (b) exposing the autologous dendritic cells to lipopeptides comprising T helper and viral CTL epitopes and/or antibody epitopes;
- and
- (c) introducing the autologous dendritic cells into the subject, thus producing an enhanced immune response to the viral infection.
A method for the prophylactic treatment of an uninfected subject, the method comprising:
- (a) harvesting cells from a subject;
- (b) generating a concentrated population of dendritic cells from the harvested cells;
- (c) exposing the dendritic cells to lipopeptides comprising T helper and viral CTL epitopes and/or antibody epitopes;
- and
- (d) re-introducing the dendritic cells into the subject.
Dependencies are inferred from the claim text.